NF2 tumor suppressor gene: A comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH

NeuroMolecular Medicine

Volumn 3, Issue 1, 2003, Pages 41-52

  Szijan, Irene ^a   Rochefort, Daniel ^b   Bruder, Carl ^c   Surace, Ezequiel ^a   Machiavelli, Gloria ^a   Dalamon, Viviana ^a   Cotignola, Javier ^a   Ferreiro, Veronica ^a   Campero, Alvaro ^a   Basso, Armando ^a   Dumanski, Jan P ^c   Rouleau, Guy A ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CNS tumors; Denaturing HPLC; Microarray CGH; NF2 mutations; Tumor suppressor gene

Indexed keywords

MUTANT PROTEIN; MERLIN;

ARTICLE; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME 22Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE DELETION; GENE LOCATION; GENE MUTATION; GENE REARRANGEMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; METASTASIS; NEURILEMOMA; NEUROFIBROMATOSIS; NF2 GENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; BRAIN TUMOR; CODON; EXON; GENETIC SCREENING; GENETICS; METABOLISM; MUTATION; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

BASE SEQUENCE; BRAIN NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CODON; DNA MUTATIONAL ANALYSIS; EXONS; GENE DELETION; GENES, NEUROFIBROMATOSIS 2; GENETIC SCREENING; HUMANS; MENINGIOMA; MUTATION; NEURILEMMOMA; NEUROFIBROMIN 2; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 0042326348     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:3:1:41     Document Type: Article

References (17)

1. Antinheimo J., Sallinen S. L., Haapasalo H., et al. (2000) Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH). Acta Neurochir. 142, 1093-1104.
2. Bianchi A. B., Hara T., Ramesh V., et al. (1994) Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumor types. Nature Genet. 6, 185-192.
3. Bieche I., Campeme M. H., Matifas F., et al. (1993) Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res. 53, 1990-1994.
4. Bretscher A., Chambers D., Nguyen R., and Reczek D. (2000) ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu. Rev. Cell Dev. Biol. 16, 113-143.
5. Bruder C. E. G., Hirvela C., Tapia-Paez I., et al. (2001) High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum. Mol. Genet. 10, 271-282.
6. Bruder C. E. G., Ichimura K., Blennow E., et al. (1999) Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22. Possible localization of a neurofibromatosis type 2 modifier gene. Genes Chromosome Cancer 25, 184-190.
7. Dunham I., Shimizu N., Roe B. A., et al. (1999) The DNA sequence of human chromosome 22. Nature 402, 489-495.
8. Evans J. J., Jeun S. S., Lee J. J., et al. (2001) Molecular slterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas. J. Neurosurg. 94, 111-117.
9. Jacoby L. B., MacCollin M., Harone R., et al. (1996) Frequency and distribution of nf2 mutations in schwannomas. Genes Chromosome Cancer 17, 45-55.
10. Knudson A. G. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820-823.
11. Kuklin A., Munson K., Gjerde D., et al. (1997/98) Detection of single-nucleotide Polymorphism with the WAVE® DNA Fragment Analysis System. Genet. Testing 1, 201-206.
12. Lutchman M. and Rouleau G. A. (1996) Neurofibromatosis type 2: a new mechanism of tumor suppression. Trends Neurosci. 19, 373-377.
13. O'Donovan M., Oefner P., Roberts S., et al. (1998) Blind analysis of denaturing high performance liquid chromatography as a tool for mutation detection. Genomics 52, 44-49.
14. Rouleau G. A., Merel P., Lutchman M., et al. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363, 515-521.
15. Ruttledge M. H., Sarrazin J., Rangaratnam S. H., et al. (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet. 6, 180-184.
16. Schleiermacher G., Peter M., Michon J., et al. (1994) Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosome Cancer 10, 275-281.
17. Sherman L. S. and Gutmann D. H. (2001) Merlin: hanging tumor suppression on the Rac. Trends Cell Biol. 11, 442-444.